Latest Breaking News On - Radiologic health - Page 5 : comparemela.com

Share this article Share this article MONMOUTH JUNCTION, N.J., Jan. 21, 2021 /PRNewswire/  CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly inflammation in critically ill and cardiac surgery patients around the world, announces the immediate appointment of David D. Cox, Ph.D., M.B.A., as Vice President – Global Regulatory Affairs. Dr. Cox was most recently Vice President of Regulatory Affairs for tissue and regenerative technologies at Integra LifeSciences Corporation.  He was responsible for successful regulatory approvals of new products and product extensions for the $480 million orthopedics and tissue technologies division.  Dr. Cox led efforts to develop U.S. FDA Premarket Approvals (PMA), 510(k)s, and Investigational New Drugs (IND), as well as international registrations under the European Union (E.U.) Medical Device Directive (MDD) and the new Medical Device Re

United statesIntegra lifesciencesEric kimVincent capponiAmy vogelJeremy fefferPhillip chanMaterial commandEuropean unionUs armyUniversity of minnesotaBlood instituteNational heartCytosorbents corporationBethel collegeCarnegie mellon university